Update 5.human-practices.md-tumour

content/5.human-practices.md

@@ -82,7 +82,7 @@ Miss Mei Lu (not her real name) is a pancreatic cancer patient who has been unde
 
 <div style="display: grid ; grid-template-columns: 70% 30% ; align-items: center">
 <div>
-Our team was impressed by China Cancer Prevention Magazine's focus on cancer prevention and research. During the session with the editor of the journal, one of our members discussed about pancreatic cancer, which has a low survival rate, and our efforts to overcome it. The editor expressed interest in publishing our research on bacteria-targeted tumor therapies. We also shared data on the increasing trend of pancreatic cancer deaths in China. We hope to collaborate with the magazine in the future.
+Our team was impressed by China Cancer Prevention Magazine's focus on cancer prevention and research. During the session with the editor of the journal, one of our members discussed about pancreatic cancer, which has a low survival rate, and our efforts to overcome it. The editor expressed interest in publishing our research on bacteria-targeted tumour therapies. We also shared data on the increasing trend of pancreatic cancer deaths in China. We hope to collaborate with the magazine in the future.
 
 </div>
 
@@ -124,7 +124,7 @@ The students gave their personal thoughts from their own perspectives. They deep
 
 <br>
 
-Mr. Yang Zhao, a teacher at Peking University Health Science Center, discussed with us about the innovation in pancreatic cancer treatment, including immunotherapy, targeted therapy, and gene therapy. He emphasized the importance of tumor research in drug development and recommended seeking guidance from experts. In drug administration and approval, he suggested collaborating with professional companies. The interview provided valuable insights for the research team's program.
+Mr. Yang Zhao, a teacher at Peking University Health Science Center, discussed with us about the innovation in pancreatic cancer treatment, including immunotherapy, targeted therapy, and gene therapy. He emphasized the importance of tumour research in drug development and recommended seeking guidance from experts. In drug administration and approval, he suggested collaborating with professional companies. The interview provided valuable insights for the research team's program.
 
 
 ::Hpdf
@@ -143,7 +143,7 @@ Mr. Yang Zhao, a teacher at Peking University Health Science Center, discussed w
 
 </br>
 
-Mr. Yang Zhao, a teacher at Peking University Health Science Center, discussed the innovation in pancreatic cancer treatment, including immunotherapy, targeted therapy, and gene therapy. He emphasized the importance of tumor research in drug development and recommended seeking guidance from experienced teachers. In drug administration and approval, he suggested collaborating with professional companies. The interview provided valuable insights for the research team's program.
+Mr. Yang Zhao, a teacher at Peking University Health Science Center, discussed the innovation in pancreatic cancer treatment, including immunotherapy, targeted therapy, and gene therapy. He emphasized the importance of tumour research in drug development and recommended seeking guidance from experienced teachers. In drug administration and approval, he suggested collaborating with professional companies. The interview provided valuable insights for the research team's program.
 
 </br>
 
@@ -213,4 +213,4 @@ The professor compared synthetic biology with classical biological technology, e
 
 <iframe src="https://static.igem.wiki/teams/4713/wiki/hp8.pdf"
             style="width: 100%;height: 100%;"></iframe>
-::
+::
\ No newline at end of file